Execution Over Strategy: The Human and Data Hurdles in Private Equity Value Creation
As private equity firms increasingly focus on operational value creation to drive performance amidst inflationary pressures and evolving market demands, the ability to execute strategy is proving just as critical as the strategy itself.
The U.S. economy has entered an era of sustained uncertainty, marked by post-pandemic structural shifts, persistent inflation, aggressive monetary tightening, and renewed fiscal risks.
The Rise of Healthtech: A Prime Opportunity for Private Equity
As healthcare systems evolve under mounting pressure for efficiency, personalization, and digital integration, Healthtech is emerging as one of the most investable frontiers in the global economy.
Record investment is flooding renewables, but the hardest problems—CCS, hydrogen, clean shipping—still need risk-tolerant capital. That’s where PE comes in.
It's Wednesday, and we're covering private equity’s dealmaking in mid-market healthcare, share of TTM capital raised in private equity, private credit growth in emerging markets and the structural long-term problem of US trade balance.
